Management of HPV-Positive Patients

Initial Risk Stratification by HPV Type

The American College of Obstetricians and Gynecologists recommends proceeding immediately to colposcopy regardless of cytology results for patients with HPV 16 or 18, due to the 17-21% 10-year cumulative risk of CIN 3 or worse 2
HPV-16 accounts for 50-60% of cervical cancer cases, with HPV-18 responsible for 10-12% 3, 4
Endocervical sampling should be performed at colposcopy, particularly for HPV-18 due to its association with adenocarcinoma 1, 2
If HPV 16 is detected with high-grade squamous intraepithelial lesion (HSIL) cytology, expedited treatment should be considered 1

For patients with normal cytology and non-16/18 high-risk HPV, the American Society for Colposcopy and Cervical Pathology recommends repeat HPV and cytology testing at 12 months 1
Low-grade squamous intraepithelial lesion (LSIL) or worse cytology warrants colposcopy in adults over 30 years, according to the National Comprehensive Cancer Network 5, 6

Colposcopy is the primary diagnostic approach following a positive cervical cancer screen, with a sensitivity ranging from 60.6% for a single biopsy to 95.6% for three biopsies 7, 5
Endocervical sampling is recommended when endocervical canal extension is suspected 7, 5

Treatment is indicated with excisional procedures (LEEP or cold-knife conization) or ablation for CIN 2 or CIN 3 (high-grade lesions), according to the National Comprehensive Cancer Network 6, 1, 2
CIN 2 may be followed without treatment in select circumstances (young women desiring fertility who are reliable with follow-up) 6

Surveillance must continue for at least 25 years after treatment for high-grade precancer, even extending past age 65, as recommended by the American Cancer Society 8, 1, 2
Initial post-treatment testing includes HPV test or co-test at 6, 18, and 30 months 1, 2

Frame HPV positivity in a neutral, non-stigmatizing context emphasizing its common, asymptomatic, and transient nature, as suggested by the Centers for Disease Control and Prevention 9
HPV infections are extremely common in sexually active women and the vast majority spontaneously resolve 3, 4

Do not delay colposcopy for HPV 16/18 positive patients based on negative cytology alone, as recommended by the American College of Obstetricians and Gynecologists 2
Do not perform immediate colposcopy for women with negative cytology but positive non-16/18 high-risk HPV, according to the American Society for Colposcopy and Cervical Pathology 1

Screen for tobacco use and perform cessation counseling, as smoking contributes to CIN progression, as recommended by the Centers for Disease Control and Prevention 9
Other cofactors that increase risk among HPV-positive women include older age, long-term oral contraceptive use (≥5 years), high parity (≥5 full-term pregnancies), and HIV infection 3